Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysis

被引：0
|
作者：
Rob W Flynn
Thomas M MacDonald
Adrian Hapca
Isla S MacKenzie
Stuart Schembri
机构：
[1] Ninewells Hospital and University of Dundee,Medicines Monitoring Unit
[2] East Block,Tayside Respiratory Research Group
[3] Ninewells Hospital,undefined
来源：
Respiratory Research | / 15卷
关键词：
COPD; Inhaled steroids; Diabetes; Pneumonia; Cataract;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Impact of Long-Acting Bronchodilators and Exposure to Inhaled Corticosteroids on Mortality in COPD: A Real-Life Retrospective Cohort Study
    Manoharan, Arvind
    Short, Phillip M.
    Anderson, William J.
    Lipworth, Brian J.
    LUNG, 2014, 192 (05) : 649 - 652
  • [22] Impact of Long-Acting Bronchodilators and Exposure to Inhaled Corticosteroids on Mortality in COPD: A Real-Life Retrospective Cohort Study
    Arvind Manoharan
    Phillip M. Short
    William J. Anderson
    Brian J. Lipworth
    Lung, 2014, 192 : 649 - 652
  • [23] Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study
    Raymakers, Adam J. N.
    Sadatsafavi, Mohsen
    Sin, Don D.
    FitzGerald, J. Mark
    Marra, Carlo A.
    Lynd, Larry D.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (06)
  • [24] Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking
    Kiri, Victor A.
    Fabbri, Leonardo M.
    Davis, Kourtney J.
    Soriano, Joan B.
    RESPIRATORY MEDICINE, 2009, 103 (01) : 85 - 90
  • [25] Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results
    Crim, C.
    Calverley, P. M. A.
    Anderson, J. A.
    Celli, B.
    Ferguson, G. T.
    Jenkins, C.
    Jones, P. W.
    Willits, L. R.
    Yates, J. C.
    Vestbo, J.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (03) : 641 - 647
  • [26] Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA
    Bourbeau, J.
    Aaron, S. D.
    Barnes, N. C.
    Davis, K. J.
    Lacasse, Y.
    Nadeau, G.
    RESPIRATORY MEDICINE, 2017, 123 : 94 - 97
  • [27] Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings
    Rogliani, Paola
    Ritondo, Beatrice Ludovica
    Gabriele, Mariachiara
    Cazzola, Mario
    Calzetta, Luigino
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (09) : 977 - 990
  • [28] The use of long acting β2-agonists, alone or in combination with inhaled corticosteroids, in Chronic Obstructive Pulmonary Disease (COPD) A risk-benefit analysis
    Cave, Alison C.
    Hurst, Martin M.
    PHARMACOLOGY & THERAPEUTICS, 2011, 130 (02) : 114 - 143
  • [29] Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis
    Cheng, Shih-Lung
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 2775 - 2784
  • [30] COPD subtypes most likely to benefit from inhaled corticosteroids (ICS): Cluster analysis
    DiSantostefano, Rachael
    Li, Hao
    Rubin, David
    Stempel, David
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345